Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-12-001153
Filing Date
2012-08-28
Accepted
2012-08-28 17:09:45
Documents
12
Period of Report
2012-05-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10k.htm 10-K 851120
2 ex31-1.htm EX-31.1 10314
3 ex31-2.htm EX-31.2 10382
4 ex32-1.htm EX-32.1 4846
5 ex32-2.htm EX-32.2 4935
6 GRAPHIC sig1.jpg GRAPHIC 5761
  Complete submission text file 0001493152-12-001153.txt   3032374

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE kdmp-20120531.xml EX-101.INS 334571
8 XBRL SCHEMA FILE kdmp-20120531.xsd EX-101.SCH 17961
9 XBRL CALCULATION FILE kdmp-20120531_cal.xml EX-101.CAL 43856
10 XBRL DEFINITION FILE kdmp-20120531_def.xml EX-101.DEF 30976
11 XBRL LABEL FILE kdmp-20120531_lab.xml EX-101.LAB 162181
12 XBRL PRESENTATION FILE kdmp-20120531_pre.xml EX-101.PRE 110082
Mailing Address 885 WEST GEORGIA STREET SUITE 1500 VANCOUVER A1 V6C 3E8
Business Address 885 WEST GEORGIA STREET SUITE 1500 VANCOUVER A1 V6C 3E8 604-324-4844
Kedem Pharmaceuticals Inc. (Filer) CIK: 0001376228 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-54455 | Film No.: 121060694
SIC: 7819 Services-Allied To Motion Picture Production